Risk factors for brain metastasis as a first site of disease recurrence in patients with HER2 positive early stage breast cancer treated with adjuvant trastuzumab

Tonyali, Onder; Coskun, Ugur; Yuksel, Sinemis; İNANÇ, MEVLÜDE; Bal, Oznur; Akman, Tulay; Yazilitas, Dogan; Ulas, Arife; KÜÇÜKÖNER, MEHMET; Aksoy, Asude; Demirci, Umut; UYSAL, MÜKREMİN; TANRIVERDİ, ÖZGÜR; Gunaydin, Yusuf; Sumbul, Ahmet; Yildiz, Ramazan; Karaca, Halit; Oksuzoglu, Berna; Ciltas, Aydin; BÜYÜKBERBER, SÜLEYMAN; BENEKLİ, MUSTAFA

doi:10.1016/j.breast.2015.11.006

Risk factors for brain metastasis as a first site of disease recurrence in patients with HER2 positive early stage breast cancer treated with adjuvant trastuzumab

Tonyali O., Coskun U., Yuksel S., İNANÇ M., Bal O., Akman T., ...More

BREAST, vol.25, pp.22-26, 2016 (SCI-Expanded, Scopus)

Publication Type: Article / Article
Volume: 25
Publication Date: 2016
Doi Number: 10.1016/j.breast.2015.11.006
Journal Name: BREAST
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.22-26
Keywords: Breast cancer, Adjuvant therapy, Trastuzumab, Brain metastasis
Dokuz Eylül University Affiliated: Yes

Abstract

Purpose: The aim of this study was to determine risk factors for brain metastasis as the first site of disease recurrence in patients with HER2-positive early-stage breast cancer (EBC) who received adjuvant trastuzumab.